Landers, J. et al. 2026. Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. Journal of Neurology Research. 16, 3 (Jan. 2026), 150–157. DOI:https://doi.org/10.14740/jnr1122.